EUROLAB
ich-q3c-residual-solvent-profiling
Impurity Profiling EMA Guideline on Genotoxic Impurities in PharmaceuticalsEMA Reflection Paper on Low Level ImpuritiesFDA Guidance: Microbial Impurities and Endotoxin LevelsFDA Guidance: Threshold of Toxicological Concern (TTC) for ImpuritiesFDA ICH M3(R2): Impurities in Safety StudiesFDA Q&A on Impurities in Generic Drug ApplicationsFDA Q&A: Managing Impurities in Complex APIsICH E14: QT Interval Evaluation and Impurity ImpactICH M7: Mutagenic Impurity Risk AssessmentICH Q10: Pharmaceutical Quality System for Impurity ManagementICH Q11: Impurity Control Strategy in Drug Substance DevelopmentICH Q12: Lifecycle Management of Impurity Control StrategyICH Q1E: Evaluation of Stability Data Related to Impurity FormationICH Q2(R1): Validation of Analytical Methods for Impurity TestingICH Q3A: Organic Impurity Profiling in Drug SubstancesICH Q3B: Impurity Testing in Finished Drug ProductsICH Q3D: Elemental Impurity Risk AssessmentICH Q3F: Impurity Guidelines for Biotechnology ProductsICH Q4B: Harmonization of Analytical Procedures for Impurity TestingICH Q5C: Impurity Monitoring in Biotechnological ProductsICH Q6A: Specifications and Acceptance Criteria for ImpuritiesICH S3A: Impurities Arising from Degradation ProductsICH S6: Biotech Product Impurity ProfilingICH S7A: Safety Pharmacology Impurity EvaluationICH S9: Impurities in Oncology ProductsISO 10993-18: Chemical Characterization and Impurity AnalysisISO 17025: Accreditation for Impurity Testing LaboratoriesJP General Rule 2.60: Limit Test for ImpuritiesPh. Eur. 2.2.28: Gas Chromatography for Impurity DetectionPh. Eur. 2.2.38: Thin-Layer Chromatography for ImpuritiesPh. Eur. 2.2.46: Chromatographic Separation for Impurity AnalysisPh. Eur. 2.4.14: Determination of Inorganic ImpuritiesPh. Eur. 2.4.20: Limit Test for Heavy Metals in ImpuritiesPh. Eur. 2.4.24: Related Substances by HPLC in APIsPh. Eur. 2.4.29: Limit Test for Sulfated Ash ImpuritiesPh. Eur. 2.5.13: Oxidizing Impurity TestsPh. Eur. 2.9.40: Uniformity of Dosage Units and Related ImpuritiesPh. Eur. 5.10: Control of Impurities in Substances for Pharmaceutical UsePh. Eur. 5.4: Impurities in Radiopharmaceutical PreparationsUSP <1010>: Analytical Data Integrity in Impurity ReportingUSP <1031>: The Biocompatibility of Materials and ImpuritiesUSP <1051>: Cleaning Validation Limits and Residual ImpuritiesUSP <1058>: Analytical Instrument Qualification for Impurity StudiesUSP <1078>: Good Manufacturing Practices for Impurity ReductionUSP <1085>: Evaluation of Impurity Method PerformanceUSP <1086>: Impurities in Drug SubstancesUSP <1088>: Forced Degradation Studies for Impurity CharacterizationUSP <1091>: Impurity Isolation and Characterization TechniquesUSP <1099>: Acceptable Analytical Performance CriteriaUSP <1121>: Bulk Pharmaceutical Chemicals and Impurity HandlingUSP <1151>: Pharmaceutical Dosage Forms and Impurity ConsiderationUSP <1191>: Stability Testing of Compounded PreparationsUSP <1222>: Terminal Sterilization Impact on ImpuritiesUSP <1224>: Transfer of Impurity Test ProceduresUSP <1225>: Validation of Compendial Procedures for ImpuritiesUSP <1226>: Verification of Compendial Procedures for Impurity DetectionUSP <1231>: Water for Pharmaceutical Purposes and Impurity EffectsUSP <1232>: Water Activity and Impurity StabilityUSP <1241>: Capsules and Shell Impurity InteractionUSP <1251>: Weighing on Analytical Balances for Micro-ImpuritiesUSP <161>: Transdermal Delivery Systems and Impurity ControlUSP <197>: Spectrophotometric Identification of ImpuritiesUSP <233>: Elemental Impurities Profiling Using ICP-MSUSP <41>: Balances Used for Impurity Weight DeterminationUSP <466>: Identification and Quantification of DegradantsUSP <467>: Residual Solvent Testing in APIs and ExcipientsUSP <476>: Impurity Profiling for New Drug ApplicationsUSP <621>: Chromatography Conditions for Impurity IdentificationUSP <730>: Plasma Spectrochemistry for Impurity ProfilingUSP <791>: pH Determination Impact on Impurity SolubilityUSP <797>: Sterile Compounding and Impurity ControlUSP <800>: Hazardous Drug Handling Based on Impurity RiskUSP <851>: Spectrophotometry and Light Scattering for ImpuritiesUSP <853>: Atomic Absorption Spectroscopy for Trace ImpuritiesUSP <857>: UV-Vis Spectroscopy for Impurity QuantificationUSP <85>: Bacterial Endotoxin Limits Related to Impurity SafetyUSP <891>: Nuclear Magnetic Resonance (NMR) for Structural ElucidationUSP <905>: Content Uniformity Related to ImpuritiesUSP <905>: Uniformity of Dosage Units Affected by ImpuritiesUSP <941>: Characterization of Impurity Solubility and pKaWHO TRS 970 Annex 2: Impurity Control in Medicines

ICH Q3C: Residual Solvent Profiling Laboratory Testing Service

Eurolabs Expertise in Residual Solvent Profiling

Introduction

Residual solvents are chemicals that remain in pharmaceutical products after the manufacturing process. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q3C: Residual Solvents guideline provides a framework for identifying and controlling residual solvents in pharmaceuticals. In this comprehensive guide, we will discuss the ICH Q3C: Residual Solvent Profiling laboratory testing service provided by Eurolab.

Standard-Related Information

Overview of Relevant Standards

The ICH Q3C: Residual Solvents guideline is a regulatory framework that governs the identification and control of residual solvents in pharmaceutical products. The following standards are relevant to this testing service:

  • ICH Q3C: Guidelines on Residual Solvents
  • USP 467: Water; Chloride; Heavy Metals; Sulfate; Sulfated Ash
  • EP 2.4.5: Chlorides (Potentiometric Titration)
  • JP 7: Chlorides; Heavy metals; Sulfates
  • ISO 3696-1: Water for analytical purposes -- Part 1: General information
  • These standards provide a framework for testing residual solvents and ensuring compliance with regulatory requirements.

    International and National Standards

    The ICH Q3C: Residual Solvent Profiling laboratory testing service is governed by international and national standards. The following organizations are involved in the development of these standards:

  • International Council for Harmonisation (ICH)
  • United States Pharmacopeia (USP)
  • European Pharmacopoeia (EP)
  • Japanese Pharmacopoeia (JP)
  • International Organization for Standardization (ISO)
  • These organizations work together to develop and maintain standards that ensure consistency and quality in laboratory testing.

    Evolution of Standards

    Standards evolve over time as new technologies and methods emerge. The ICH Q3C: Residual Solvents guideline is regularly updated to reflect changes in regulatory requirements and scientific advancements. Eurolab stays up-to-date with the latest developments in standardization and ensures that our testing services meet the evolving needs of our clients.

    Specific Standard Numbers and Scope

    The following are specific standard numbers and their scope:

  • ICH Q3C (R5): Guidelines on Residual Solvents
  • Identifies and controls residual solvents in pharmaceutical products

    Provides guidelines for testing and reporting residual solvents

  • USP 467: Water; Chloride; Heavy Metals; Sulfate; Sulfated Ash
  • Tests for water, chloride, heavy metals, sulfate, and sulfated ash in pharmaceutical products

  • EP 2.4.5: Chlorides (Potentiometric Titration)
  • Tests for chlorides in pharmaceutical products using potentiometric titration

    These standards provide a comprehensive framework for testing residual solvents and ensuring compliance with regulatory requirements.

    Standard Compliance Requirements

    Compliance with standard requirements is essential to ensure the quality and safety of pharmaceutical products. The following are industry-specific examples:

  • Pharmaceutical Industry: Manufacturers must comply with ICH Q3C: Residual Solvents guidelines
  • Cosmetic Industry: Manufacturers must comply with ISO 3696-1: Water for analytical purposes -- Part 1: General information
  • Compliance with standard requirements is essential to ensure the quality and safety of pharmaceutical products.

    Standard Requirements and Needs

    Overview of Business and Technical Reasons

    The ICH Q3C: Residual Solvent Profiling laboratory testing service is necessary due to the following reasons:

  • Regulatory Compliance: Manufacturers must comply with ICH Q3C: Residual Solvents guidelines
  • Product Safety: Testing residual solvents ensures product safety and reliability
  • Quality Assurance: Testing residual solvents ensures quality assurance and compliance
  • These reasons highlight the importance of testing residual solvents in pharmaceutical products.

    Consequences of Not Performing This Test

    Failure to test for residual solvents can have severe consequences:

  • Regulatory Non-Compliance: Manufacturers may face regulatory action
  • Product Safety Issues: Residual solvents can affect product safety and reliability
  • Quality Assurance Problems: Testing residual solvents ensures quality assurance and compliance
  • These consequences highlight the importance of testing residual solvents in pharmaceutical products.

    Industries and Sectors That Require This Testing

    The following industries and sectors require ICH Q3C: Residual Solvent Profiling laboratory testing:

  • Pharmaceutical Industry
  • Cosmetic Industry
  • Food Industry
  • These industries require testing residual solvents to ensure compliance with regulatory requirements.

    Risk Factors and Safety Implications

    Residual solvents can pose risks to human health and safety. The following are some of the risk factors:

  • Carcinogenicity: Residual solvents can be carcinogenic
  • Toxicity: Residual solvents can be toxic
  • Environmental Impact: Residual solvents can affect the environment
  • These risk factors highlight the importance of testing residual solvents in pharmaceutical products.

    Conclusion

    In conclusion, Eurolabs ICH Q3C: Residual Solvent Profiling laboratory testing service is an essential tool for ensuring compliance with regulatory requirements and product safety. Our team of experts is dedicated to providing high-quality testing services that meet the evolving needs of our clients.

    References

  • International Council for Harmonisation (ICH). (2022). Guidelines on Residual Solvents.
  • United States Pharmacopeia (USP). (2022). Water; Chloride; Heavy Metals; Sulfate; Sulfated Ash.
  • European Pharmacopoeia (EP). (2022). Chlorides (Potentiometric Titration).
  • Japanese Pharmacopoeia (JP). (2022). Chlorides; Heavy metals; Sulfates.
  • International Organization for Standardization (ISO). (2022). Water for analytical purposes -- Part 1: General information.
  • Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers